Global /China /Healthcare /Drug Manufacturers - General /600829
chevron_leftBack
HPGC Renmintongtai Pharmaceutical Corp. logo

HPGC Renmintongtai Pharmaceutical Corp.

600829
SSE: 600829 Delayed
9.72CNY 0.4%
1.44 USD
As of 15 June 2026, HPGC Renmintongtai Pharmaceutical Corp. has a market cap of $829.47M USD, ranking #11848 globally and #3466 in China. It ranks #1079 in the Healthcare sector, and #403 in the Drug Manufacturers - General industry.
Global Rank
11848
Country Rank
3466
Sector Rank
1079
Industry Rank
403
Key Stats
Market Cap
$829.47MUSD
5.61B CNY
Enterprise Value
$810.44MUSD
5.48B CNY
Revenue (TTM)
$1.56BUSD
10.54B CNY
EBITDA (TTM)
$36.5MUSD
246.99M CNY
Net Income (TTM)
$20.16MUSD
136.46M CNY
EBITDA Margin
2.3%
Profit Margin
1.3%
PE Ratio
41.1
PS Ratio
0.5
PB Ratio
1.8
EV/EBITDA
19.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Cong Feng Gu open_in_new
Employees
2,870
Founded
1950
Website
hyrmtt.com.cn open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.4% 0.5% -3% -17% 15% 36%

News

Loading...

Markets

Exchange Ticker Price
Shanghai Stock Exchange
MIC: XSHG
PRIMARY
600829
哈药集团人民同泰医药股份有限公司 Class A
ISIN: CNE000000G05
Shares Out.:
579.889M1 Shares Float: 112.935M2
TV:
SA:
YF:
GF:
BA:
MS:
9.72 CNY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About HPGC Renmintongtai Pharmaceutical Corp.

HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese and Western patent medicines, Chinese herbal medicines and slices, chemical preparations, antibiotics, biological products, biochemical drugs, medical devices, and health products, as well as tonic health, daily necessities, and cosmetics products. It also provides logistics services, including warehousing and distribution services; and hospital services comprising medical treatment, scientific research, prevention, health care, rehabilitation, and hemodialysis and kidney disease treatment. Further, it is involved in distribution of medical equipment and operation of Chinese medicine and outpatient clinics. It serves its products through e-commerce platform, a chain of direct stores and online B2C, O2O, etc. The company was founded in 1950 and is headquartered in Harbin, China. HPGC Renmintongtai Pharmaceutical Corporation is a subsidiary of Harbin Pharmaceutical Group Co., Ltd.

Similar Companies

Industry: Drug Manufacturers - General (China)
Name
Market Cap diff.
PE
$53.92B
364.89B CNY
6K%
44.9
603259
$49.7B
336.36B CNY
6K%
17.2
$28.52B
223.48B HKD
3K%
35.7
$18.8B
147.32B HKD
2K%
162.3
$16.53B
111.89B CNY
2K%
-
9926
$16.01B
125.46B HKD
2K%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
92K%
38.1
JNJ
$547.28B
66K%
26.4
ABBV
$360.63B
43K%
97.4
$321.52B
256.25B CHF
39K%
19.9
AZN
$288.84B
215.59B GBP
35K%
27.6
NOVN
$274.65B
218.9B CHF
33K%
20.5
chevron_leftBack